Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jun;478(6):1215-1219.
doi: 10.1007/s00428-020-02942-1. Epub 2020 Oct 1.

Evidence of a common cell origin in a case of pancreatic mixed intraductal papillary mucinous neoplasm-neuroendocrine tumor

Affiliations
Free article
Case Reports

Evidence of a common cell origin in a case of pancreatic mixed intraductal papillary mucinous neoplasm-neuroendocrine tumor

Marco Schiavo Lena et al. Virchows Arch. 2021 Jun.
Free article

Abstract

Recently, the term mixed neuroendocrine non-neuroendocrine neoplasms (MiNEN) has been proposed as an umbrella definition covering different possible combinations of mixed neuroendocrine-exocrine neoplasms. Among these, the adenoma plus neuroendocrine tumor (NET) combination is among the rarest and not formally recognized by the 2019 WHO Classification. In this setting, the debate between either collision tumors or true mixed neoplasms is still unsolved. In this report, a pancreatic intraductal papillary mucinous neoplasm (IPMN) plus a NET is described, and the molecular investigations showed the presence in both populations of the same KRAS, GNAS, and CDKN2A mutations and the amplification of the CCND1 gene. These data prove clonality and support a common origin of both components, therefore confirming the true mixed nature. For this reason, mixed neuroendocrine-exocrine neoplasms, in which the exocrine component is represented by a glandular precursor lesion (adenoma/IPMN) only, should be included into the MiNEN family.

Keywords: CDKN2A mutation; Cyclin D1 amplification; Intraductal papillary mucinous neoplasm; KRAS and GNAS mutation; Mixed neuroendocrine non-neuroendocrine neoplasms; Pancreatic neuroendocrine tumor.

PubMed Disclaimer

References

    1. WHO (2019) Classification of Tumours Editorial Board, Digestive System Tumours, 5th edn. IARC Press, Lyon
    1. Bosman FT, Carneiro F, Hruban RH, Theise ND (eds) (2010) WHO classification of tumours of the digestive system, 4th edn. IARC Press, Lyon
    1. La Rosa S, Ucella S, Molinari F, Savio A, Mete O et al (2018) Mixed adenoma well-differentiated neuroendocrine tumor (MANET) of the digestive system: an indolent subtype of mixed neuroendocrine-nonneuroendocrine neoplasm (MiNEN). Am J Surg Pathol 42(11):1503–1512 - DOI
    1. Manuel-Vazquez A, Ramia JM, Latorre-Fraqua R, Valle-Rubio A, Arteaga-Peralta V, Ramiro-Pérez C et al (2018) Pancreatic neuroendocrine tumors and intraductal papillary mucinous neoplasm of the pancreas: a systematic review. Pancreas. 47(5):551–555 - DOI
    1. Woischke C, Schaaf CW, Yang HM, Vieth M, Veits L, Geddert H, Märkl B, Stömmer P, Schaeffer DF, Frölich M, Blum H, Vosberg S, Greif PA, Jung A, Kirchner T, Horst D (2017) In-depth mutational analyses of colorectal neuroendocrine carcinomas with adenoma or adenocarcinoma components. Mod Pathol 30(1):95–103 - DOI

Publication types

MeSH terms

Substances